· after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a...
4
· after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the